Teva Sells $15B In Bonds To Help Fund Actavis Generics Deal
Teva Pharmaceutical Industries Ltd. is selling $15 billion in bonds, which will go toward its purchase of Allergan PLC's generic pharmaceuticals business, the company said Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article